FENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF  TYPE 2 DIABETIC RETINOPATHY

Parpibaeva Dinara Ayupovna., Salayeva Muborak Saidabdullayevna., Salimova Nargiza Djurabaevna., Ergashov Nodirbek Shermuxamat o’g’li., Buvamuxamedova Nasiba Taxirovna

dc.contributor.author	Parpibaeva Dinara Ayupovna., Salayeva Muborak Saidabdullayevna., Salimova Nargiza Djurabaevna., Ergashov Nodirbek Shermuxamat o’g’li., Buvamuxamedova Nasiba Taxirovna
dc.date.accessioned	2023-12-12T12:40:10Z
dc.date.available	2023-12-12T12:40:10Z
dc.date.issued	2023
dc.identifier.issn	2751-1731
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9648
dc.description.abstract	Today, diabetes mellitus is considered a “pandemic”, and the number of patients with this disease and its complications is increasing day by day. Diabetes mellitus is a severe complication of diabetic retinopathy that leads to blindness and disability in people. Timely detection, prevention and effective treatment of this complication are among the urgent tasks facing endocrinologists. Today, taking into account such risk factors as hyperglycemia, dyslipidemia and uncontrolled arterial hypertension, which play a leading role in the pathogenesis of complications of diabetic retinopathy, many studies are being carried out in the world on the effective complex treatment of this complication. This article talks about the next study conducted at the multidisciplinary clinic of the Tashkent Medical Academy.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Spectrum Journal of Innovation, Reforms and Developmen	en_US
dc.subject	DM - Diabetes mellitus, Diabetic retinopathy, Dyslipidemia, Fenofibrate (Tricor).	en_US
dc.title	FENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHY	en_US
dc.type	Article	en_US